Latest stories

  • in

    NMC gives deadline to medical students abroad to fulfill deficiencies on pending applications for eligibility certificate

    Referring to the pending applications for issuance of Eligibility Certificates, the National Medical Commission (NMC) has now set a 30 days deadline for the students pursuing medical courses abroad to complete their applications in the eligibility web portal and fulfill their deficiencies. The Ethics and Medical Registration Board (EMRB) of NMC has further warned that […] More

  • in

    NMC gives Deadline to Medical Students Abroad to fulfill deficiencies on pending applications for Eligibility Certificate

    New Delhi: Referring to the pending applications for issuance of Eligibility Certificates, the National Medical Commission (NMC) has now set a 30 days deadline for the students pursuing medical courses abroad to complete their applications in the eligibility web portal and fulfill their deficiencies. The Ethics and Medical Registration Board (EMRB) of NMC has further warned […] More

  • in

    DME Uttrakhand Invites Applications For Increasing Seat intake in nursing colleges, details

    DME Uttrakhand Invites Applications For Increasing Seat intake in nursing colleges, details

    Uttrakhand: The Director of Medical Education (DME Uttrakhand) has invited applications to increase seats in nursing colleges across the state. Both government and private nursing colleges can apply. The application has to be submitted to the Authority. The month-wise schedule has been announced. For the month of April and May, the colleges can get the […] More

  • in

    RGUHS Invites Online Applications For PhD 2023-24, Entrance Exam To Be Held On 4th May

    RGUHS Invites Online Applications For PhD 2023-24, Entrance Exam To Be Held On 4th May

    Karnataka: Rajiv Gandhi University of Health Sciences (RGUHS) has invited online applications for PhD courses in Medical, Dental, Pharmacy, Nursing Health Sciences and Physiotherapy 2023-2024. The candidates will have to do online registration. They must ensure that the printout of their application with all enclosures mentioned in the brochure reaches the RGUHS on or before […] More

  • in

    USFDA accepts Pfizer supplemental new drug applications for BRAFTOVI plus MEKTOVI

    New York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Applications (sNDAs) for BRAFTOVI (encorafenib) + MEKTOVI (binimetinib) for patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as detected by an FDA-approved test. The Prescription Drug User Fee Act […] More